See also this year's filing and all EDGAR filings for this company.
PDF Report 0001377121_2020_Protagonist_Therapeutics_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.009323741007194245, 'aggregate_val': 154917000, 'exp_sum': 156375000, 'exp_to_value': {'AssetsCurrent': 145311000, 'IntangibleAssetsNetIncludingGoodwill': 0, 'PropertyPlantAndEquipmentNet': 1681000, 'remainder_Assets': 9383000}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001377121')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001377121, Protagonist Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 145,311,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,681,000 |
| 3 | remainder_Assets | 7,925,000 |
| 4 | LiabilitiesCurrent | 35,406,000 |
| 5 | LiabilitiesNoncurrent | 29,753,000 |
| 6 | remainder_Liabilities | 9,794,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,749,000 |
| 9 | ResearchAndDevelopmentExpense | 65,003,000 |
| 10 | remainder_Expenses | -522,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 3,043,000 |
| 13 | remainder_ComprehensiveNetIncome | 12,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 154,917,000 |
| 1 | Liabilities | 74,953,000 |
| 2 | Expenses | 80,230,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 79,964,000 |
| 5 | NetIncome | -77,187,000 |
| 6 | ComprehensiveNetIncome | -77,181,000 |
| 7 | BaseVar | 156,577,500 |
| 8 | EconomicCapitalRatio | 0.525 |
Edgar->Model Mapping
Feature Distribution
Change over Time
